A comparative study of the postoperative allogeneic blood-sparing effect of tranexamic acid versus acute normovolemic hemodilution after total knee replacement

Anesthesia and Analgesia

Volumn 89, Issue 6, 1999, Pages 1382-1387

  Zohar, Edna ^a   Fredman, Brian ^a   Ellis, Martin ^b   Luban, Ilya ^a   Stern, Avraham ^c,d   Jedeikin, Robert ^a,c  

^a Dept of Anesth and Critical Care ^*  (Israel)

^b Ichilov Medical Center   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ISOFLURANE; NITROUS OXIDE; SUXAMETHONIUM; THIOPENTAL; TRANEXAMIC ACID; VECURONIUM;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMATOCRIT; HEMODILUTION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; JOINT PROSTHESIS; KNEE SURGERY; MALE; ORTHOPEDIC SURGERY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SURGICAL PATIENT; TOTAL KNEE REPLACEMENT;

EID: 0032704257     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199912000-00010     Document Type: Article

References (27)

1. Goodnough LT, Brecher ME, Kanter H, AuBuchon JP. Blood transfusion. Part 1. N Engl J Med 1999;340:438-47.
2. Goodnough LT, Brecher ME, Kanter H, AuBuchon JP. Blood transfusion. Part 2. N Engl J Med 1999;340:525-33.
3. Birkmeyer JD, Goodnough LT, Aubuchon P, et al. The cost effectiveness of preoperative autologous blood donation in total hip and knee replacement. Transfusion 1993;33:544-51.
4. Birkmeyer JD, Aubuchon P, Littenberg B, et al. The cost effectiveness of preoperative autologous donation in coronary bypass surgery. Ann Thorac Surg 1994;57:161-9.
5. National Heart, Lung, and Blood Institute Expert Panel on the Use of Autologous Blood. Transfusion alert: use of autologous blood. Transfusion 1995;35:703-11.
6. Linden JV. Autologous blood errors and incidents. Transfusion 1994;34:28S.
7. Winslow RM. Blood substitutes: minireview. Prog Clin Biol Res 1989;319:305-23.
8. Dietz NM, Joyner MJ, Warner MA. Blood substitutes: fluids, drugs, or miracle solutions? Anesth Analg 1996;82:390-405.
9. Olsfanger D, Jedeikin R, Metser U, et al. Acute normovolaemic Haemodilution and idiopathic scoliosis surgery: effects on homologous blood requirements. Anaesth Intensive Care 1993;21: 429-31.
10. Milam JD, Austin SF, Nilhill MR, et al. Use of sufficient hemodilution to prevent coagulopathies following surgical correction of cyanotic congenital heart disease. J Thorac Cardiovasc Surg 1985;89:623-9.
11. Spahn DR, Zollinger A, Schlumpf RB, et al. Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 1996;82:681-6.
12. Spahn DR, Leone BJ, Reves JG, Pasch T. Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 1994;78:1000-21.
13. Landow L. Perioperative hemodilution. Can J Surg 1987;30: 321-5.
14. Brown RS, Thwaites BK, Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations. Anesth Analg 1997; 85:963-70.
15. Boylan JF, Klinck JR, Sandler AN, et al. Tranexamic acid reduces blood loss, transfusion requirements and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 1996;85:1043-8.
16. Verstraete M. Clinical applications of inhibitors of fibrinolysis. Drugs 1985;29:236-61.
17. Marmor L, Avoy DR, McCabe A. Effects of fibrinogen concentrates on blood loss in total knee replacement. Clin Orthop 1991;273:136-8.
18. Leclrec JR, Greets WH, Desjardens L, et al. Prevention of deep vein thrombosis after major knee surgery: a randomized, double-blind trial comparing low molecular weight heparin fragment (Enoxaparin) to placebo. Thromb Haemost 1992;67: 417-23.
19. Colwell CW, Spiro TE, Trowbridge AA, et al. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis after elective knee replacement: Enoxaparin Clinical Trial Group. Clin Orthop 1995;321:19-27.
20. Hiippala S, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee replacement. Anesth Analg 1997;84:839-44.
21. Olsfanger D, Fredman B, Goldstein B, et al. Acute normovolaemic haemodilution decreases postoperative allogeneic blood transfusion after total knee replacement. Br J Anaesth 1997;79: 317-21.
22. Petaja J, Myllynen P, Myllyla G, Vahtera E. Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand 1987; 153:647-51.
23. Kruithof EKO, Nicolosa G, Bachmann F. Plasminogen activator inhibitor: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood 1987;70:1645-53.
24. Laks H, Handin RI, Martin V, Pilon RN. The effects of acute normovolemic hemodilution on coagulation and blood utilization in major surgery. J Surg Res 1976;20:225-30.
25. Gillon J, Thomas MJG, Desmong MJ. Acute normovolemic hemodilution. Transfusion 1996;36:640-3.
26. Leclerc JR, Gent M, Hirsh J, et al. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. Arch Intern Med 1998;158:873-8.
27. Heit JA, Berkowitz SD, Bona R, et al. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group. Thromb Haemost 1997; 77:32-8.